Literature DB >> 17966227

A rare case of female pelvic mass: angioleiomyoma of the broad ligament.

L Cobellis1, E Pecori, F Rigatti, C Scaffa, M Rotondi, E M Messalli.   

Abstract

Angioleiomyoma is a benign mesenchymal neoplasm composed of smooth muscle cells and thick-walled vessels. It is usually found in the skin of the lower extremities. Angioleiomyoma is a very rare tumor among the ever-expanding repertoire of growth variants described in benign uterine leiomyoma. More rare is a solitary tumor of the broad ligament. Thus angioleiomyoma of the broad ligament is an extremely rare benign tumor of the female pelvis. In this report a 52-year-old woman with a one-year history of abdominal pain was admitted to our hospital. Gynaecological and ultrasonography exams showed a large mass with increased vascularization in the right adnexal region. The patient underwent total hysterectomy and bilateral salpingo-oophorectomy. The site of the benign mass was the left broad ligament of the uterus. On pathologic examination of the specimen, the tumor was diagnosed as angioleiomyoma. We present a case of angioleiomyoma of the broad ligament because of its extreme rarity and the large size of the tumor.

Entities:  

Mesh:

Year:  2007        PMID: 17966227

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  3 in total

1.  Uterine angioleiomyoma complicated by consumptive coagulopathy.

Authors:  Marci Handler; Fariborz Rezai; Kristin G Fless; Mikhail Litinski; Paul C Yodice
Journal:  Gynecol Oncol Case Rep       Date:  2012-04-06

2.  Successfully removed uterine angioleiomyoma by robot-assisted laparoscopic myomectomy.

Authors:  Hyunkyung Kim; Jin-Ju Lee; Yonghee Choi; Minkyoung Lee; Hye-Jin Hwang; Youn-Jee Chung; Hyun-Hee Cho; Mee-Ran Kim
Journal:  Obstet Gynecol Sci       Date:  2018-04-09

3.  Leiomyosarcoma of the Broad Ligament With Fever Presentation: A Case Report and Review of Literature.

Authors:  Shahla Chaichian; Abolfazl Mehdizadehkashi; Kobra Tahermanesh; Bahram Moazzami; Fatemeh Jesmi; Moezedinjavad Rafiee; Katayoun Goharimoghaddam
Journal:  Iran Red Crescent Med J       Date:  2016-03-12       Impact factor: 0.611

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.